Last updated 50 days ago
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
60 patients around the world
Available in Spain, United States, Mexico
Carrick Therapeutics Limited
4Research sites
60Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro de Investigación Clínica de Oaxaca - Oaxaca
Recruiting
Cryptex Investigación Clínica
Recruiting
SOLTMED SMO
Recruiting
Actualidad Basada en la Investigación del Cáncer
Recruiting
StudySUMIT-BC
SponsorCarrick Therapeutics Limited
Conditions
Breast Cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05963984
